TagUSA

Factors associated with syphilis seroprevalence in women with and at-risk for HIV infection…

F

Aaron KJ, Brill I, Causey-Pruitt Z, et al Factors associated with syphilis seroprevalence in women with and at-risk for HIV infection in the Women’s Interagency HIV Study (1994–2015) Sexually Transmitted Infections 2022;98:4-10. Abstract: Objective – Syphilis rates among women in the USA more than doubled between 2014 and 2018. We sought to identify correlates of syphilis among women...

Understanding Migrant Sex Workers: Factsheet

U

Butterfly (Asian and Migrant Sex Workers Support Network, Canada ), August 2018 This 8-page factsheet is produced by Butterfly, a organisation formed in Canada by sex workers, social workers, legal and health professionals in 2014. It provides support to, and advocates for, the rights of Asian and migrant sex workers. The organization is founded upon the belief that sex workers are entitled to...

Attractiveness, profile-picture face visibility, and unprotected receptive anal intercourse in young MSM using online dating applications

A

Wongsomboon Val, Sietins Emils, Webster Gregory D. (2021) Sexual Health 18, 212-220. Abstract: Background: We examined links among face visibility on dating-profile pictures, self-perceived attractiveness, condom use self-efficacy, and unprotected receptive anal intercourse (URAI) in 223 young men who have sex with men (YMSM; ages 18–24 years) using online dating applications (e.g. Grindr)...

Women Living With HIV Require Better Mental Health Diagnostics and Interventions

W

Infectious Disease Advisor, April 9, 2021 Mental health conditions affect women living with HIV (WLWH) at substantially higher rates compared with men living with HIV (MLWH) and HIV-negative women. However, treatment regimens and research literature related to mental health do not reflect the proportion of affected WLWH. In a narrative review published online in the January 2021 issue of...

FDA Approves Cabenuva, the First Complete Long-Acting Injectable HIV Treatment

F

Poz.com, January 21, 2021 On January 21, the Food and Drug Administration (FDA) in the USA approved the first complete injectable HIV treatment regimen that does not require daily pills. Cabenuva, from ViiV Healthcare, is administered only once a month. It is approved for people with an undetectable viral load on their current therapy who wish to switch to a long-acting regimen. Cabenuva consists...

U.S. FDA Approves Evofem Biosciences’ Phexxi™, the First Non-Hormonal Prescription Gel for the Prevention of Pregnancy

U

Evofem Biosciences via PRNewswire, May 22nd 2020  Evofem Biosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. Phexxi is the first non-hormonal, on-demand...

Your sidebar area is currently empty. Hurry up and add some widgets.